SureTrader
Home > Boards > US OTC > Cannabis > Lexaria Bioscience Corp. (LXRP)

LXRP's Breakthrough Lipid-Based Delivery System Revolutionizes Delivery of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NetworkNewsWire Member Profile
Member Level 
Followed By 36
Posts 3,743
Boards Moderated 35
Alias Born 10/18/16
160x600 placeholder
Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) Edgar (US Regulatory) - 2/7/2018 3:12:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/6/2018 5:09:24 PM
Cannabis Deals Cross the Billion-Dollar Mark in Canada NetworkNewsWire - 2/6/2018 8:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/30/2018 6:06:21 AM
Fast-Growing Cannabis Industry Drives Biotech Research, Innovative Medical Therapy Development NetworkNewsWire - 1/25/2018 8:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/22/2018 6:03:52 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/12/2018 3:38:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/9/2018 4:03:44 PM
Intriguing Research into Pathways to Limit Nicotine, Quit Cigarette Use NetworkNewsWire - 1/9/2018 8:45:00 AM
Securities Registration: Business Combination (s-4) Edgar (US Regulatory) - 1/5/2018 5:30:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/26/2017 6:41:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2017 4:17:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/14/2017 3:45:53 PM
Merger and Acquisition Activity is Heating Up in the Cannabis Industry NetworkNewsWire - 12/7/2017 8:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/5/2017 11:55:57 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/1/2017 4:57:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/1/2017 4:40:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/1/2017 4:23:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/1/2017 3:54:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/29/2017 2:07:53 PM
Annual Report (10-k) Edgar (US Regulatory) - 11/27/2017 3:22:37 PM
Lexaria Bioscience Files Innovative New Patent Application InvestorsHub NewsWire - 11/9/2017 10:12:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2017 4:33:04 PM
Bioabsorption Breakthrough Shows Promise for Tobacco, Cannabinoids, Medication NetworkNewsWire - 11/2/2017 8:45:00 AM
Lexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECHTM Delivery of THC, NSAIDs, and Nicotine ... InvestorsHub NewsWire - 11/1/2017 9:32:17 AM
NetworkNewsWire Member Level  Tuesday, 10/03/17 12:46:02 PM
Re: None
Post # of 20845 
Compensated Awareness Post - View Disclaimer
LXRP's Breakthrough Lipid-Based Delivery System Revolutionizes Delivery of Cannabinoids and More

Pioneering biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed a breakthrough lipid-based system that facilitates more efficient delivery of bioactive compounds—not only enhancing bio-absorption and bioavailability but also improving taste, smell and the onset of action. Lexaria intends to out-license this patented and proprietary technology, and the company has already applied this delivery technology to its line of products, which includes ViPova, Lexaria Energy and TurboCBD. An article further discussing this reads: “Lexaria’s novel technology, DehydraTECH™, ticks all these boxes by infusing the molecules of organically sourced hemp oil, high in cannabidiol (CBD), inside the molecules of lipids. Lipids seem a natural choice, since the human endocannabinoid system is itself lipid-based. Using them as a vehicle for delivering cannabinoids in curatives results in more absorption, less waste and, just as importantly, fewer side effects (http://nnw.fm/7Yuym). With DehydraTECH, a little hemp oil goes a long way, improving the healthful benefits and, of course, saving money.”

To view the full article, visit http://nnw.fm/yHk3L

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information about Lexaria, visit www.lexariabioscience.com.


\
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist